Skip to main content
. 2019 Apr 17;176(1):27–36. doi: 10.1007/s10549-019-05233-9

Fig. 2.

Fig. 2

Distribution of types of endocrine therapy over patients. TAM Tamoxifen, AI Aromatase inhibitor, ET Endocrine therapy